IL6 and gastric cancer: In summary, our work uncovers a novel oncogenic axis in EBV-associated gastric cancer, whereby EBV-encoded miR-BART20-3p directly targets PPARα to unleash IL-6–driven inflammatory signaling, thereby promoting tumor cell proliferation and migration.